Characterization of Monoclonal Antibodies That Recognize Canine CD34
Peter A. McSweeney(Mesoblast (United States)), Richard A. Nash(Colorado Blood Cancer Institute), Ljiljana Križanac-Bengez(University of Washington), Elizabeth A. Wayner(University of Washington), Brenda M. Sandmaier(University of Washington), Rainer Storb(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Robert G. Andrews(University of Washington), Benedetto Bruno(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), Philip M. Wallace(Bristol-Myers Squibb (United States)), Katherine A. Rouleau(University of Washington)
Cited by 4
Related Papers
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
|New England Journal of Medicine|2017|6k
Chronic graft-versus-host syndrome in man
|The American Journal of Medicine|1980|2.4k
Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1–2 trial
|The Lancet Oncology|2018|2.3k
HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation Cyclophosphamide
|Biology of Blood and Marrow Transplantation|2008|1.9k
KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell Lymphoma
|New England Journal of Medicine|2020|1.9k